BioLineRx (BLRX) Operating Income Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 55.96% |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | 26.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.12% |
| Sep 30, 2025 | 32.19% |
| Jun 30, 2025 | 32.84% |
| Mar 31, 2025 | 26.73% |
| Dec 31, 2024 | 12.46% |
| Sep 30, 2024 | 4.66% |
| Jun 30, 2024 | 3.94% |
| Mar 31, 2024 | 3.99% |
| Dec 31, 2023 | -46.77% |
| Sep 30, 2023 | -38.52% |
| Jun 30, 2023 | -21.22% |
| Mar 31, 2023 | -8.99% |
| Dec 31, 2022 | 3.73% |
| Sep 30, 2022 | -2.14% |
| Jun 30, 2022 | -5.48% |
| Mar 31, 2022 | -2.91% |
| Dec 31, 2021 | 2.12% |
| Sep 30, 2021 | -0.03% |
| Jun 30, 2021 | -4.38% |
| Mar 31, 2021 | 6.33% |
| Dec 31, 2020 | 8.59% |
| Sep 30, 2020 | 12.99% |
| Jun 30, 2020 | -2.33% |
| Mar 31, 2020 | -8.87% |
| Dec 31, 2019 | -29.01% |
| Sep 30, 2019 | -13.96% |
| Jun 30, 2019 | -18.77% |
| Mar 31, 2019 | -13.89% |
| Dec 31, 2018 | -19.73% |
| Sep 30, 2018 | -19.91% |
| Jun 30, 2018 | -11.19% |
| Mar 31, 2018 | -15.28% |
| Dec 31, 2017 | -13.94% |
| Sep 30, 2017 | -20.13% |
| Jun 30, 2017 | -9.92% |
| Mar 31, 2017 | -9.15% |
| Dec 31, 2016 | -24.24% |
| Sep 30, 2016 | -11.07% |
| Jun 30, 2016 | 5.84% |
| Mar 31, 2016 | 16.59% |